Hamilton Lane stock: what recent returns are telling investors

Hamilton Lane (HLNE) has drawn investor attention after a period of weak share performance, with the stock down 7.7% over the past month and 17.3% over the past 3 months.

Over the past year, the stock has declined 41.4%, while the year to date move is also a 41.4% decline. This sets a cautious backdrop as investors review the company’s fundamentals and valuation signals.

At the current share price of $80.10, the stock’s weak short term share price returns sit beside a modestly positive 3 year total shareholder return. Together, these factors point to fading momentum as investors reassess growth prospects and risks.

If Hamilton Lane’s recent swings have you rethinking concentration in a single stock, this could be a good moment to broaden your search with 20 top founder-led companies

With Hamilton Lane’s share price under pressure but the stock trading at a discount to some analyst targets and intrinsic estimates, the key question now is whether this signals a buying opportunity or whether the market is already pricing in future growth.

Most Popular Narrative: 41.1% Undervalued

Hamilton Lane’s most followed narrative places fair value at $136.00 per share, well above the last close of $80.10, which frames the recent share price weakness in a very different light.

Strong momentum in Hamilton Lane's evergreen and specialized fund products, including recent launches in infrastructure, multi-strategy, and Asia-focused vehicles, reflects expanding demand from both institutional and retail clients seeking alternatives to traditional markets. This supports accelerating fee-earning AUM growth and increasing fee-related revenues.

Want to see what sits behind that confidence in fee growth and earnings power? The narrative leans on rising margins, faster revenue expansion, and a future profit multiple that undercuts many peers. The full story connects those inputs into one coherent fair value roadmap.

Result: Fair Value of $136.00 (UNDERVALUED)

However, this upbeat fee and earnings story can unravel if regulatory costs rise faster than expected, or if fee compression and tougher competition squeeze profitability.

Next Steps

With sentiment clearly split between risks and rewards, this is a good time to move quickly, review the full picture, and weigh the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Hamilton Lane has sharpened your focus on risk and reward, do not stop here. Broaden your watchlist so you are not missing potential opportunities elsewhere.

• Target steadier compounding by reviewing companies offering robust income streams through 8 dividend fortresses
• Hunt for quality at a reasonable price by scanning stocks that currently screen as 44 high quality undervalued stocks
• Prioritise resilience first by filtering for companies highlighted in the 70 resilient stocks with low risk scores

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.